# A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy Participants

> **NCT06502379** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 147 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** AZD8965
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06502379
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-02
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-11-15
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06502379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06502379, "A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06502379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*